Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse

Personalized cancer immunotherapy targeting patient-specific cancer/testis antigens (CTA) and neoantigens may benefit from large-scale tumor human leukocyte antigen (HLA) peptidome (immunopeptidome) analysis, which aims to accurately identify antigens presented by tumor cells. Although significant e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Proteomics
Autors principals: Rijensky, Nataly Mancette, Blondheim Shraga, Netta R., Barnea, Eilon, Peled, Nir, Rosenbaum, Eli, Popovtzer, Aron, Stemmer, Solomon M., Livoff, Alejandro, Shlapobersky, Mark, Moskovits, Neta, Perry, Dafna, Rubin, Eitan, Haviv, Itzhak, Admon, Arie
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8015002/
https://ncbi.nlm.nih.gov/pubmed/32451349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.RA119.001876
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars